Su W, Wang W, Zhang G, Yang L
Clin Epigenetics. 2025; 17(1):48.
PMID: 40083014
PMC: 11907984.
DOI: 10.1186/s13148-025-01852-w.
Tiwari A, Paithane U, Friedlein J, Tashiro K, Saulnier O, Barbosa K
bioRxiv. 2025; .
PMID: 40027648
PMC: 11870553.
DOI: 10.1101/2025.02.17.638454.
Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A
Mol Cancer. 2025; 24(1):58.
PMID: 40011944
PMC: 11863469.
DOI: 10.1186/s12943-025-02267-0.
Yang C, da Silva M, Howell J, Larochelle J, Liu L, Gunraj R
Int J Mol Sci. 2024; 25(21).
PMID: 39519307
PMC: 11546996.
DOI: 10.3390/ijms252111754.
Singh S, Braun C, Carroll-Portillo A, Coffman C, Lin H
Microorganisms. 2024; 12(9).
PMID: 39338507
PMC: 11434237.
DOI: 10.3390/microorganisms12091833.
Relationship of Signaling Pathways between RKIP Expression and the Inhibition of EMT-Inducing Transcription Factors SNAIL1/2, TWIST1/2 and ZEB1/2.
Bustamante A, Baritaki S, Zaravinos A, Bonavida B
Cancers (Basel). 2024; 16(18).
PMID: 39335152
PMC: 11430682.
DOI: 10.3390/cancers16183180.
Deletion of the RGD motif from the penton base in oncolytic adenoviruses enhances antitumor efficacy of combined CAR T cell therapy.
Morales-Molina A, Rodriguez-Milla M, Garcia-Rodriguez P, Hidalgo L, Alemany R, Garcia-Castro J
Mol Ther Oncol. 2024; 32(3):200863.
PMID: 39290319
PMC: 11406095.
DOI: 10.1016/j.omton.2024.200863.
GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma.
Shen N, Luo M, Gu W, Gong M, Lei H, Bi L
Oncogene. 2024; 43(33):2504-2516.
PMID: 38969770
DOI: 10.1038/s41388-024-03096-z.
Copy number variation analysis identifies MIR9-3 and MIR1299 as novel miRNA candidate genes for CAKUT.
Zivotic I, Kolic I, Cvetkovic M, Spasojevic-Dimitrijeva B, Zivkovic M, Stankovic A
Pediatr Nephrol. 2024; 39(9):2655-2665.
PMID: 38656454
DOI: 10.1007/s00467-024-06381-x.
Macrophage-derived exosomal HMGB3 regulates silica-induced pulmonary inflammation by promoting M1 macrophage polarization and recruitment.
Qin X, Niu Z, Chen H, Hu Y
Part Fibre Toxicol. 2024; 21(1):12.
PMID: 38454505
PMC: 10918916.
DOI: 10.1186/s12989-024-00568-8.
NF-κB in biology and targeted therapy: new insights and translational implications.
Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M
Signal Transduct Target Ther. 2024; 9(1):53.
PMID: 38433280
PMC: 10910037.
DOI: 10.1038/s41392-024-01757-9.
Lipopolysaccharide (LPS) stimulation of Pancreatic Ductal Adenocarcinoma (PDAC) and macrophages activates the NLRP3 inflammasome that influences the levels of pro-inflammatory cytokines in a co-culture model.
G Paremes Sivam H, Chin B, Gan S, Ng J, Gwenhure A, Chan E
Cancer Biol Ther. 2023; 24(1):2284857.
PMID: 38018872
PMC: 10783839.
DOI: 10.1080/15384047.2023.2284857.
Dexmedetomidine Protects Cortical Neurons from Propofol-Induced Apoptosis via Activation of Akt-IKK-NF-κB Signaling Pathway by α-adrenoceptor.
Sun W, Li W, Zhang M, Du Q
Appl Biochem Biotechnol. 2023; 196(8):4849-4861.
PMID: 37979083
DOI: 10.1007/s12010-023-04768-4.
Targeting Rev-Erbα to protect against ischemia-reperfusion-induced acute lung injury in rats.
Chu S, Liao W, Pao H, Wu S, Tang S
Respir Res. 2023; 24(1):247.
PMID: 37828537
PMC: 10571317.
DOI: 10.1186/s12931-023-02547-7.
The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects.
Karatrasoglou E, Dimou M, Piperidou A, Lakiotaki E, Korkolopoulou P, Vassilakopoulos T
Int J Mol Sci. 2023; 24(18).
PMID: 37762410
PMC: 10531792.
DOI: 10.3390/ijms241814110.
Development of a novel, clinically relevant anoikis-related gene signature to forecast prognosis in patients with prostate cancer.
Liu X, Wang K
Front Genet. 2023; 14:1166668.
PMID: 37719710
PMC: 10499615.
DOI: 10.3389/fgene.2023.1166668.
Erythropoietin Suppresses the Hepatic Fibrosis Caused by Thioacetamide: Role of the PI3K/Akt and TLR4 Signaling Pathways.
Elbaset M, Mohamed B, Moustafa P, Mansour D, Afifi S, Esatbeyoglu T
Oxid Med Cell Longev. 2023; 2023:5514248.
PMID: 37649466
PMC: 10465256.
DOI: 10.1155/2023/5514248.
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.
Glaviano A, Foo A, Lam H, Yap K, Jacot W, Jones R
Mol Cancer. 2023; 22(1):138.
PMID: 37596643
PMC: 10436543.
DOI: 10.1186/s12943-023-01827-6.
Inhibitors of the PI3K/AKT/mTOR pathway in human malignancies; trend of current clinical trials.
Davoodi-Moghaddam Z, Jafari-Raddani F, Delshad M, Pourbagheri-Sigaroodi A, Bashash D
J Cancer Res Clin Oncol. 2023; 149(16):15293-15310.
PMID: 37594532
DOI: 10.1007/s00432-023-05277-x.
Anoikis resistance--protagonists of breast cancer cells survive and metastasize after ECM detachment.
Dai Y, Zhang X, Ou Y, Zou L, Zhang D, Yang Q
Cell Commun Signal. 2023; 21(1):190.
PMID: 37537585
PMC: 10399053.
DOI: 10.1186/s12964-023-01183-4.